Vaccines — Editors

Journal Contact

Vaccines Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Editorial Office

Prof. Dr. Diane M. Harper
Professor of Family and Geriatric Medicine, Obstetrics and Gynecology, Bioengineering, Epidemiology and Population Health, Health Promotions and Behavioral Sciences, University of Louisville School of Medicine, 501 East Broadway, Louisville, KY 40202, USA
Tel. +1 502 852 3320
Interests: cervical cancer prevention; HPV vaccine, HPV prevention; HPV cure; CIN detection; CIN cure; quality of life; shared decision making; communications

Assistant Editor
Ms. Qingjuan Yang
MDPI Beijing Office, Suite 2011, Ruidu International Center, No. 1 Cuijingbeili, Tongzhou District, Beijing, 101100, China
Tel. +86 10 8152 1170; Fax: +86 10 5901 1089

Production Editor
Dr. Martyn Rittman
MDPI AG, Klybeckstrasse 64, CH-4057 Basel, Switzerland

Editorial Board

Prof. Dr. Pedro L. Alonso
Barcelona Center for International Health Research(CRESIB), University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
Tel. +34 93 227 5706; Fax: +34 93 227 9853
Interests: public health; host-pathogen interaction; Malaria; viral and bacterial infections; HIV/AIDS and STI’s

Dr. Rolf Billeskov
Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark Institute of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
Tel. +45 3268 8144; Fax: +45 3268 3035
Interests: immunology; T cells; tuberculosis; polyfunctionality of T cells; T cell avidity; vaccines

Dr. Joseph E. Blaney, Jr.
Emerging Viral Pathogens Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research Plaza, Room 1A-124, Fort Detrick, MD 21702, USA
Tel. +1 301 631 7211; Fax: +1 301 631 7387
Interests: Viral vaccines, pathogenesis of emerging viruses, biodefense, animal model development

Prof. Dr. Thierry Boon
de Duve Institute, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels Branch Avenue Hippocrate, 74 B1.74.03, B-1200 Brussels, Belgium
Tel. +32 2762 5484; Fax: +32 2764 7590
Interests: The work of our group is aimed at understanding why some metastatic melanoma patients show tumor regression following vaccination whereas most patients do not. Recent results suggest that a local immunosuppressive environment at the tumor sites may be the main barrier to the efficacy of immunotherapy.

Prof. Dr. Olga Borges
Center for Neuroscience and Cell Biology & Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Tel. +351 239 488 428
Interests: focussed on the development of polymeric carriers as adjuvants for mucosal vaccination (protein and DNA) and examination of the interactions of delivery systems with biological targets in vitro and in vivo

Dr. Sandra S. Chaves
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30333, USA
Tel. + 1 404 639 2797; Fax: +1 404 929 2729
Interests: infectious disease epidemiology; influenza; duration of vaccine-induced immunity; influenza treatment; influenza prevention

Dr. Genoveffa Franchini
Animal Models & Retroviral Vaccine Section, Vaccine Branch, National Cancer Institute, National Institute of Health, 9000 Rockville Pike, Bethesda MD, 20892, USA
Tel. +1 301 496 2386; Fax: +1 301 402 0055
Interests: immunology, virology, vaccines; HTLV; SIV; animal models; vaccine development

Prof. Dr. Eli Gilboa
Department of Microbiology and Immunology, Dodson Interdisciplinary Immunotherapy Institute and the Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, 1550 NW 10th Avenue, Room 211, Papanicolaou Cancer Research Building, Miami, FL 33136, USA
Tel. +1 305 243 1767; Fax: +1 305 243 4409
Interests: My laboratory is using murine tumor models to develop a multi-pronged strategy to elicit clinically-useful antitumor immune responses in cancer patients. The current main strategy is to develop immune modulatory agents composed of short oligonucleotides (siRNAs, aptamers, antagomirs) that are targeted to the tumor or the tumor-activated immune system by conjugation to oligonucleotide aptamer ligands

Prof. Dr. Marc P. Girard
University Paris 7, French National Academy of Medicine, 49 rue D'Aubigny, FR 69003 Lyon, France
Tel. +33 680 237 682
Interests: viral vaccine research and development: HIV vaccines, influenza vaccines, lentiviruses; vaccinology in general; and anti-viral immune responses: neutralizing antibodies, ADCC and ADCVI, CD8+ T cell responses, innate immunity responses, mucosal immunity

Dr. Elena A. Govorkova
Department of Infectious Diseases, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA
Tel. +1 901 595 2243; Fax: +1 901 595 8559
Interests: antiviral drugs for the control of influenza infection, including H5N1 influenza viruses: assessment of antiviral drug efficacy in vitro and in vivo; evaluation of viral fitness; combination chemotherapy; influenza vaccines: immunogenicity and protective efficacy

Dr. Guido Grandi
Novartis Vaccines and Diagnostics, Research Center, Via Fiorentina 1, 53100 Siena, Italy
Tel. +39 0577 243506; Fax: +39 0577 278514
Interests: bacterial infectious diseases; group A streptococcus; group B streptococcus; S. aureus; Chlamydia; vaccine development; proteomics; genomics; high throughput technologies

Prof. Dr. Chinnaswamy Jagannath
Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center, 6400 Fannin Street, MSB 2.200, Houston, TX 77030, USA
Tel. +1 713 500 5353
Interests: vaccines for tuberculosis; TLR signaling and adjuvants; Th1 immunity and T cells; Dendritic cells and macrophages-pathogen survival
Contribution: Special Issue: Tuberculosis Vaccines

Dr. Aisha O. Jumaan
TEPHNET-Centers for Disease Control and Prevention, 3216 74th Place SE. Mercer Island, WA 98040, USA
Tel. +1 404 432 8861
Interests: vaccines; vaccine preventable diseases; vaccine effectiveness; infectious diseases; breast and cervical cancers; maternal and child health

Prof. Dr. Matti Osmo Antero Lehtinen
School of Health Sciences, University of Tampere, Sorinkatu 1, 33014 Tampere, Finland
Tel. +358 40 5437862; Fax: +358 3 35518057
Interests: cancer; tumor viruses; immune response; infectious disease epidemiology; sexually transmitted infections; translational medicine

Prof. Dr. Margaret A. Liu
1 ProTherImmune, 3656 Happy Valley Road Lafayette, CA 94549, USA
2 Karolinska Institute, Stockholm SE-17177, Sweden
3. Adjunct Professor, Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 USA
Tel. +1 925 299 2959; Fax: +1 925 299 2959
Interests: vaccine technologies; DNA vaccines; cellular immune responses; HIV Vvccines; global health
Contribution: Special Issue: DNA Vaccines

Prof. Dr. Abu Salim Mustafa
Department of Microbiology, Faculty of Medicine, Kuwait University PO Box 24923, Safat 13110, Kuwait
Tel. +965 24896505; Fax: +965 25332719
Interests: Tuberculosis; vaccines; immunodiagnosis; immuno-pathogenesis
Contribution: Special Issue: Tuberculosis Vaccines

Prof. Dr. Toshi Nagata
Department of Health Science, Hamamatsu University School of Medicine, 1-20-1 Handa-yama, Higashi-ku, Hamamatsu 431-3192, Japan
Tel. +81 53 435 2332
Interests: intracellular bacteria; T cell responses; DNA vaccines; HLA; antigen presentation; tuberculosis

Prof. Dr. Sven-Eric Olsson
Karolinska Institute at Danderyd Hospital, SE-182 88 Stockholm, Sweden
Tel. +46 8655 5608; Fax: +46 8753 2276
Interests: HPV vaccines; dysplasias and treatment options; immunological memory; cervical cancer screeningHPV vaccines; dysplasias and treatment options; immunological memory; cervical cancer screening programmes programmes

Dr. Mark Pearson
Research Fellow, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia
Tel. +61 742 321 865; Fax: +61 742 321 492
Interests: Mark’s major research focus involves looking at the functions of proteins from human parasites (specifically helminths, or worms) and how these molecules interact with the host immune system. He is particularly interested in understanding these processes in the context of developing vaccines against parasites of third world populations and finding novel therapies for autoimmune disorders such as asthma

Prof. Dr. John K. Rose
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Tel. +1 203 785 6184; Fax: +1 203 785 7467
Interests: virology; vaccine and gene expression vectors based on rhabdoviruses; membrane protein assembly, transport and targeting; viral assembly

Prof. Dr. Pramod K. Srivastava
Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USA
Tel. +1 860 679 4444; Fax: +1 860 679 7905
Interests: antigen presentation by MHC I and MHC II molecules; immune response to cancer; viral immunity and autoimmunity

Dr. Stanley S. Tai
Department of Microbiology, College of Medicine, Howard University, 520 “W” Street, NW, Washington, DC 20059, USA
Tel. +1 202 806 4677; Fax: +1 202 667 9589
Interests: pneumococcal vaccine; respiratory bacterial pathogens; bacterial pathogenesis
Contribution: Special Issue: Pneumococcal Vaccine in the 21st Century

Prof. Dr. Sjoerd H. van der Burg
Department of Oncology, Section Experimental Cancer Immunology and Therapy, K1-P, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
Tel. +31 526 1180
Interests: The aim of my laboratory is to optimally implement immunotherapy as treatment modality for patients with solid tumors. The program is focused on the exploration of key factors in host-tumor interactions that determine successes and failures in immune control of cancer in order to drive the improvement of our immunotherapeutic strategies against solid tumors. Keywords: therapeutic vaccines, immunotherapy, peptides, HPV, chronic viral infections, cancer

Prof. Dr. Zhou Xing
McMaster Immunology Research Centre, Department of Pathology & Molecular Medicine, Rm. MDCL-4012, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S 4K1, Canada
Tel. +1 905 525 9140 ext. 22354; Fax: +1 905 522 6750
Interests: infectious diseases; pulmonary infectious disease; T cell immunity; vaccines; mucosal vaccination

Dr. Shi-Yu Yang
Division of Surgery & Interventional Science, University College London, Rowland Hill Street, London, NW3 2PF, UK
Interests: colorectal cancer, stem cells; regenerative medicine

Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert